PRINCETON, N.J., Jan. 12, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for ...
E Ink (8069.TWO), the originator, pioneer, and global commercial leader in ePaper technology, today announced they will be ...
The Company’s fourth quarter and full-year 2024 financial and operational results are preliminary and are subject to the completion of the Company’s 2024 audit. Audited full-year 2024 and unaudited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback